Chenyu Lin
House Staff

Duke Hematology/Oncology Fellow
Malignant hematologist with an interest in clinical trials, novel cell therapies / stem cell transplant, and tele-oncology.

Residency: Northwestern University, Internal Medicine
Medical School: University of Chicago Pritzker School of Medicine (M.D.)
Undergraduate: Yale University (B.S.)

Current Research Interests

My primary research interest involves investigating novel allogeneic cellular therapy and stem cell transplant strategies in the treatment of advanced hematologic malignancies. With Dr. Matthew McKinney and Dr. Richard Lopez, we are currently designing an early phase clinical trial studying an ex vivo phosphoantigen-expanded gamma-delta T cell immunotherapy targeting aggressive B cell lymphomas and acute leukemias. On the transplant side, under the mentorship of Dr. Mitchell Horwitz and Dr. Anthony Sung, I have been working on secondary analyses assessing health-related quality of life and the long-term durability of omidubicel, an ex vivo expanded stem cell product derived from umbilical cord blood. My research in allogeneic hematopoietic stem cell transplantation has also expanded to explore the use of Syk inhibition in the prevention and treatment of chronic graft versus host disease, under the guidance of Dr. Stefanie Sarantopoulos and Dr. Mitchell Horwitz. My other clinical/research interests include tele-oncology and ctDNA biomarkers.

Current Appointments & Affiliations

Contact Information

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.